Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website https://jh.elmerpub.com

Case Report

Volume 15, Number 4, August 2026, pages 214-218


Post-Transplant Cyclophosphamide-Based Related Haploidentical Transplantation for Adult Diamond-Blackfan Anemia: Long-Term Survival and Review

Figure

↓  Figure 1. Clinical course of the patient. Adult DBA engrafted after related PT-Cy haplo-PBSCT. Acute skin GVHD developed. However, tacrolimus was discontinued due to malabsorption failing to reach therapeutic levels, and GVHD was managed with methylprednisolone and MMF. GI-GVHD precluded oral medication absorption, requiring management with methylprednisolone monotherapy. After engraftment, the patient achieved complete independence from RBC transfusions. aGVHD: acute graft-versus-host disease; Bu: busulfan (6.4 mg/kg); DBA: Diamond-Blackfan anemia; Flu: fludarabine (150 mg/m2); G-CSF: granulocyte-colony stimulating factor; haplo-PBSCT: haploidentical peripheral blood stem cell transplantation; Hb: hemoglobin; Mel: melphalan (140 mg/m2); MMF: mycophenolate mofetil; mPSL: methylprednisolone; PT-Cy: posttransplant-cyclophosphamide; ret: reticulocyte count; WBC: white blood cell.
Figure 1.

Table

↓  Table 1. Reports of Post Transplant Cyclophosphamide Allogeneic Stem Cell Transplantation in Adult Diamond-Blackfan Anemia
 
StudyAge/sexPrior therapyDonor typeHLAStem cell sourceConditioning regimenCD34+ cells/kg (/106)Engraftment Neutrophil RBC/PlateletGVHD acute chronicInfection by day100OutcomeF/U(M)
BM: bone marrow; Bu: busulfan; Cy: cyclophosphamide; F/U: follow-up; Flu: fludarabine; GI: gastrointestinal; GVHD: graft-versus-host disease; HLA: human leukocyte antigen; Mel: melphalan; PBSC: peripheral blood stem cell; rATG: rabbit anti-thymocyte globulin; TBI: total body irradiation.
Leick, et al
39/MSteroidBrotherHaploBMFlu/Cy/TBI2Gy (+rATG?)1.54210NoneAlive63
N/A / 43none
39/MSteroidCousinHaploBMFlu/Cy/TBI2Gy (+rATG?)3.6921I (skin stage 1)NoneAlive12
TestosteroneN/A / 35Limited (eye)
Wirk, et al
35/MSteroidUnrelatedMatchPBSCFlu/Cy/rATG/TBI4Gy5.94140NoneAlive15
N/A / 14None
Our case21/FSteroidFatherHaploPBSCFlu/Mel/Bu5.3616II (skin, GI)NoneAlive62
20 / 31Limited (eye)